Intervention group: 2 capsules of omega-3 containing 360 mg EPA and 240 mg DHA for 2 months
Sponsors
Vice-chancellor for research, Tabriz University of Medical Sciences, Nutritional Research Center,Tabriz University of Medical Sciences
Conditions
polycystic ovary syndrome.
Polycystic ovarian syndrome
Phase 2
Effect of omega-3 fatty acids supplementation in polycystic ovary syndrome patients
Active, not recruitingIRCT201011083664N3
Start: 2010-11-22Target: 64Updated: 2018-02-22
Effect of omega-3 fatty acids supplementation on serum levels of malondialdehyde, total antioxidant capacity and paraoxonase1 in polycystic ovary syndrome patients
Active, not recruitingIRCT201106243664N5
Start: 2010-11-22Target: 60Updated: 2018-02-22